You are currently viewing a new version of our website. To view the old version click .

4 Results Found

  • Article
  • Open Access
2 Citations
2,982 Views
17 Pages

A Robust FISH Assay to Detect FGFR2 Translocations in Intrahepatic Cholangiocarcinoma Patients

  • Lei Zhang,
  • Hao Zheng,
  • Linyu Xu,
  • Si You,
  • Yuanyuan Shen,
  • Yang Han and
  • Steve Anderson

FGFR fusions retaining the FGFR kinase domain are active kinases that are either overexpressed or constitutively activated throughout diverse cancer types. The presence of FGFR translocations enhances tumor cell proliferation and contributes to signi...

  • Review
  • Open Access
57 Citations
9,559 Views
24 Pages

Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma

  • Erin Flynt,
  • Kamlesh Bisht,
  • Vinidhra Sridharan,
  • María Ortiz,
  • Fadi Towfic and
  • Anjan Thakurta

24 January 2020

Multiple myeloma (MM) is the second most common hematological cancer and is characterized by genetic features including translocations, chromosomal copy number aberrations, and mutations in key oncogene and tumor suppressor genes. Dysregulation of th...

  • Case Report
  • Open Access
2,403 Views
10 Pages

Donor Cell Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: A Case Report and Literature Review

  • Giovanni Micheloni,
  • Annalisa Frattini,
  • Marta Donini,
  • Stefano Dusi,
  • Anna Leszl,
  • Annamaria Di Meglio,
  • Martina Pigazzi,
  • Antonio Musio,
  • Marco Zecca and
  • Tommaso Mina
  • + 10 authors

16 November 2023

The patient reported here underwent hematopoietic stem cell transplantation (HSCT) due to chronic granulomatous disease (CGD) caused by biallelic mutations of the NCF1 gene. Two years later, he developed AML, which was unexpected and was recognized v...

  • Review
  • Open Access
6 Citations
3,268 Views
21 Pages

Agnostic Administration of Targeted Anticancer Drugs: Looking for a Balance between Hype and Caution

  • Svetlana N. Aleksakhina,
  • Alexander O. Ivantsov and
  • Evgeny N. Imyanitov

Many tumors have well-defined vulnerabilities, thus potentially allowing highly specific and effective treatment. There is a spectrum of actionable genetic alterations which are shared across various tumor types and, therefore, can be targeted by a g...